Tracking of human embryonic stem cell-derived mesenchymal stem cells in premature ovarian failure model mice.
Animals
Cell Differentiation
Cell Movement
Cell Tracking
/ methods
Cells, Cultured
Cyclophosphamide
Disease Models, Animal
Female
Green Fluorescent Proteins
/ genetics
Human Embryonic Stem Cells
/ cytology
Humans
Lung
/ cytology
Mesenchymal Stem Cell Transplantation
/ methods
Mesenchymal Stem Cells
/ cytology
Mice, Inbred C57BL
Microscopy, Fluorescence
/ methods
Myocardium
/ cytology
Ovary
/ cytology
Primary Ovarian Insufficiency
/ chemically induced
Cyclophosphamide
Green fluorescent protein
Mesenchymal stem cell
Premature ovarian failure
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
05 11 2021
05 11 2021
Historique:
received:
28
07
2021
revised:
18
08
2021
accepted:
22
08
2021
pubmed:
7
9
2021
medline:
27
11
2021
entrez:
6
9
2021
Statut:
ppublish
Résumé
Premature ovarian failure (POF) is defined by amenorrhea, hypoestrogenism, elevated gonadotropin levels, and infertility. Chemotherapeutic agents are the most gonadotoxic agents that lead to POF. Although some previous studies have presented that mesenchymal stem cells (MSCs) transplantation could rescue the ovary function of POF animal models through the paracrine pathway, these mechanisms require further investigation. However, mechanisms of embryonic stem cell-derived MSCs (ES-MSCs) therapeutic effects on POF animal models have not been fully investigated yet. This study aimed to evaluate the migration and distribution of ES-MSCs in a model of chemotherapy-induced POF. Female mice received intraperitoneal injections of cyclophosphamide (Cy) to induce POF. Then, MSCs were labeled with green fluorescent protein (GFP) in vitro and injected intravenously into POF mice, and the distribution of MSCs was dynamically monitored at 1 week after transplantation. We harvested the lungs, liver, spleen, ovaries, heart, and kidneys 1 week after transplantation. The sections of these tissues were observed under the fluorescent microscope. More than 70% MSCs were successfully labeled with GFP at 72 h after labeling. MSCs were uniformly distributed in multiple organs and tissues including lungs, liver, spleen, ovaries, heart, and kidneys of POF mice. In mice, at 1week after intravenous transplantation, GFP labeled ES-MSCs were observed in the lungs, liver, spleen, ovaries, heart, and kidneys of POF mice, and the number of GFP labeled ES-MSCs in lungs, ovaries, and heart were higher than that in the spleen, kidneys, and liver. Our results revealed intravenously implanted ES-MSCs could migrate into the various tissues in chemotherapy-induced damaged POF mice.
Identifiants
pubmed: 34487961
pii: S0006-291X(21)01246-8
doi: 10.1016/j.bbrc.2021.08.063
pii:
doi:
Substances chimiques
Green Fluorescent Proteins
147336-22-9
Cyclophosphamide
8N3DW7272P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6-11Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.